Florida Technology Seed Capital Fund — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
RxMP Therapeuticsrxmpt.cominMar 2021
RxMP Therapeutics develops systemically-delivered hemostatic agents based on red cell-derived microparticles, intended to stop or prevent excessive bleeding from trauma, surgery, and bleeding disorders.
BiotechMedical DevicesMiami, US
Rifat Pamukcu(Executive Officer, Director, Promoter)inJy Wenche(Executive Officer, Director, Promoter)
BoardSue Van(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.